Mike Mensinger Buys 33,350 Shares of Beta Bionics, Inc. (NASDAQ:BBNX) Stock

Beta Bionics, Inc. (NASDAQ:BBNX) insider Mike Mensinger bought 33,350 shares of the stock in a transaction on Friday, January 31st. The stock was purchased at an average price of $17.00 per share, for a total transaction of $566,950.00. Following the purchase, the insider now directly owns 59,019 shares of the company’s stock, valued at approximately $1,003,323. This represents a 129.92 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Beta Bionics Trading Up 1.1 %

Shares of NASDAQ BBNX opened at $23.00 on Wednesday. Beta Bionics, Inc. has a 52 week low of $21.72 and a 52 week high of $24.50.

About Beta Bionics

We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.